Vasohibin 1 Polyclonal Antibody, FITC Conjugated
Product Specifications
Background
Angiogenesis inhibitor. Inhibits migration, proliferation and network formation by endothelial cells as well as angiogenesis. This inhibitory effect is selective to endothelial cells as it does not affect the migration of smooth muscle cells or fibroblasts. Does not affect the proliferation of cancer cells in vitro, but inhibits tumor growth and tumor angiogenesis. Acts in an autocrine manner. Inhibits artery neointimal formation and macrophage infiltration. Exhibits heparin-binding activity.
Synonyms
KIAA1036; Vasohibin-1; VASH1; VASH
Gene ID
22846
Swiss Prot
Q7L8A9
Cellular Locus
Secreted
Host
Rabbit
Cross Reactivity
Human, Rat
Immunogen
281-365/365
Target
Vasohibin 1
Clonality
Polyclonal
Isotype
IgG
Conjugation
FITC
Source
KLH conjugated synthetic peptide derived from human VASH1
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
494nm/518nm
Concentration
1µg/µl
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
22846
Predicted Cross Reactivity
Mouse, Dog, Cow, Pig, Horse, Rabbit
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
032318-APC 200 µL
ATXN2L, CT (ATXN2L, A2D, A2LG, A2LP, A2RP, Ataxin-2-like protein, Ataxin-2 domain protein, Ataxin-2-related protein) (APC) discontinued
Ask
View Details